Targeting of the ETS factor GABPalpha disrupts neuromuscular junction synaptic function

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• GA-binding protein (GABP) is known to regulate neuromuscular proteins in vitro.
• A mutation in the acetylcholine receptor epsilon subunit gene, regulated by GABP, is linked to congenital myasthenic syndrome.

Purpose of the Study:

• To investigate the in vivo function of GABPalpha in neuromuscular junction and skeletal muscle development.
• To elucidate the role of GABP in postsynaptic gene regulation and neuromuscular function.

Main Methods:

• Conditional gene targeting in mice to circumvent embryonic lethality.
• Analysis of diaphragm and soleus muscles for morphological and functional changes.
• Assessment of acetylcholine receptor cluster distribution and neurotransmission properties.

Main Results:

• Mutant mice exhibited altered neuromuscular junction morphology and acetylcholine receptor distribution.
• Reduced receptor function and altered neurotransmission were observed.
• Skeletal muscle showed decreased expression of acetylcholine receptor epsilon and increased gamma subunit.

Conclusions:

• GABP transcription factor is essential for the structural formation and functional integrity of neuromuscular junctions.
• GABP regulates the expression of key postsynaptic genes, impacting neuromuscular function.
• Dysregulation of GABP contributes to neuromuscular disorders like congenital myasthenic syndrome.